After approval, a manufacturer plans to increase the batch size of an immediate-release tablet and to change a manufacturing process parameter. The regulatory affairs group must determine the appropriate reporting category based on the potential impact of these changes. Which framework is specifically referenced in the CPGP body of knowledge for assessing such post-marketing changes?